TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)

Condition:   Asthma
Interventions:   Drug: CHF 5993 200/6/12.5 µg;   Drug: CHF 1535 200/6 µg;   Drug: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg
Sponsor:   Chiesi Farmaceutici S.p.A.
Not yet recruiting – verified February 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days